Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

EMCURE PHARMS LTD

  • FDA Approval
  • Nov. 22, 2024, 15:16 UTC
  • 50
  • 0 comments

FDA approve DOLUTEGRAVIR

Comment Full text

ICEUTICA OPERATIONS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 35
  • 0 comments

FDA approve MELOXICAM

Comment Full text

DR REDDYS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 40
  • 0 comments

FDA approve PROGESTERONE

Comment Full text

SCILEX PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 31
  • 0 comments

FDA approve CELECOXIB

Comment Full text

IBSA INST BIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 37
  • 0 comments

FDA approve DICLOFENAC EPOLAMINE

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 39
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 39
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text

CIPLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 38
  • 0 comments

FDA approve EMTRICITABINE

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 30
  • 0 comments

FDA approve DICLOFENAC

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 36
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text
  • Previous
  • 261
  • 262
  • 263
  • 264
  • 265
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122407)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin